ViewsWeek Views from around the world
despite drawing tens of millions of dollars in government funding, Ebola research has dragged on for years, and the handful of biotechnology firms that are developing vaccines and treatments for the hemorrhagic fever were caught unawares by the epidemic.
Read More »Washington Wakes Up to Ebola Threat
